Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-11-083082
Filing Date
2011-03-30
Accepted
2011-03-30 17:10:31
Documents
3
Effectiveness Date
2011-03-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 25507
2 GRAPHIC g167397pc1.jpg GRAPHIC 229554
3 GRAPHIC g167397pc2.jpg GRAPHIC 204576
  Complete submission text file 0001193125-11-083082.txt   625127
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-22873 | Film No.: 11722891
SIC: 2835 In Vitro & In Vivo Diagnostic Substances